Fidelity Investments’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
CFM
VP
MA
BFM
CCM
PLC
Fidelity Investments's MXCT Position: Q2 2026 in Review
Fidelity Investments reduced its MaxCyte (MXCT) stake by 5.1% in Q2 2026, selling an estimated $9.76K and leaving 180,338 shares worth $222K. The position accounts for ﹤0.01% of the portfolio, ranked #3613.
Fidelity Investments first reported a position in MXCT in Q1 2022 and has held it in 18 quarters since. The position peaked at $14.4M in Q1 2024. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.
- Fidelity Investments held 180,338 shares of MaxCyte worth $222K as of Q2 2026.
- Fidelity Investments sold 9,788 MaxCyte shares in Q2 2026, an estimated $9.76K.
- MaxCyte made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3613 holding.
- Fidelity Investments first reported a position in MaxCyte in Q1 2022 and has held it in 18 quarters since.
- Fidelity Investments's MaxCyte position peaked at $14.4M in Q1 2024.
- 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.